Shire Pharmaceuticals Group Plc
New Data From Shire Aim To Help Close the Diagnosis and Treatment Gap for People With Hemophilia
Zug, Switzerland (ots/PRNewswire) - Shire presentations at EAHAD 2017 underscore the company's leadership in improving global standards of care Shire plc (LSE: SHP, NASDAQ: SHPG), the leading biotechnology company focused on serving individuals with rare diseases, presented its new estimate of the Global Annual Bleed Rate (GABR), an effort to build on current global ...